Women's health Clinical Trials in Boston, MA

As of August 2026, 135 paid clinical trials are recruiting for Women's health in Boston, Massachusetts. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

136 clinical trials for Women's health

·Clear filters·

Email me when a new women's health trial opens in Boston, MA.

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

for Breast Cancer

Sites in Boston +6 more locations

Sponsor: Regor Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT05304962·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

for Breast Cancer

Sites in Boston +1 more location

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05950945·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for Biliary Tract Cancer

Sites in Boston +5 more locations

Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All·Age: 18+

Code: NCT06239194·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for Breast Neoplasms

Sites in Boston +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06686394·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

IKS014 in Advanced Solid Tumors That Express HER2

for Breast Cancer

Sites in Boston +3 more locations

Sponsor: Iksuda Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT05872295·Phase 1·Recruiting·Listed May 2023

Apply to this trial

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for Epithelial Ovarian Cancer

Sites in Boston +4 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: Female·Age: 18+

Code: NCT06469281·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Comprehensive Outcomes for After Cancer Health

for Ovarian Cancer

Sites in Boston +3 more locations

Sponsor: Pack Health

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05349227·Recruiting·Listed Apr 2022

Apply to this trial

Apple Women's Health Study

for Menstrual Cycle

1 location in Boston

Sponsor: Apple Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04196595·Recruiting·Listed Dec 2019

Apply to this trial

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

for Lung Cancer (Diagnosis)

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT07675967·Recruiting·Listed Jun 2026

Apply to this trial

Oncoplastic Surgery Outcomes Database

for Breast Cancer

1 location in Boston

Sponsor: Tufts Medical Center

Sex: Female·Age: 18+

Code: NCT07597837·Recruiting·Listed May 2026

Apply to this trial

A Study of Isoquercetin in People With Ovarian Cancer

for Ovarian Cancer

Sites in Boston +7 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT07303894·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Postnatal Exercise to Activate Baby's Brown Fat

for Childhood Obesity Prevention

Sites in Boston +1 more location

Sponsor: Joslin Diabetes Center

Sex: Female·Age: 18 - 45·Accepts healthy volunteers

Code: NCT07467694·Recruiting·Listed Mar 2026

Apply to this trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

for Breast Cancer

Sites in Boston, Winchester +1098 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 18 - 60

Code: NCT05879926·Phase 3·Recruiting·Listed May 2023

Apply to this trial

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for Ovarian Carcinoma

Sites in Boston, Springfield +479 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 35 - 50

Code: NCT04251052·Recruiting·Listed Jan 2020

Apply to this trial

E-Mindfulness Approaches for Living After Breast Cancer

for Breast Cancer

Sites in Boston, Stoneham +372 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18 - 50

Code: NCT06748222·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

for Estrogen-receptor-positive Breast Cancer

1 location in Boston

Sponsor: Kristina A. Fanucci

Sex: All·Age: 18+

Code: NCT07222215·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Distance-Based Exercise to Preserve Function and Prevent Disability

for Localized Malignant Solid Neoplasm

Sites in Boston +17 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT07059884·Recruiting·Listed Jul 2025

Apply to this trial

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for Endometrial Cancer

Sites in Boston, Worcester +73 more locations

Sponsor: Canadian Cancer Trials Group

Sex: Female·Age: 18+

Code: NCT05640999·Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for Breast Cancer

Sites in Boston, Brighton +44 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT04893109·Phase 2·Recruiting·Listed May 2021

Apply to this trial

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

for Breast Cancer

Sites in Boston +9 more locations

Sponsor: Ana C Garrido-Castro, MD

Sex: All·Age: 18+

Code: NCT06533826·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

for Breast Cancer

Sites in Boston, Wellesley Hills +9 more locations

Sponsor: American College of Radiology

Sex: Female·Age: 45 - 74·Accepts healthy volunteers

Code: NCT05625659·Recruiting·Listed Nov 2022

Apply to this trial

Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome

for Endometrial Cancer

1 location in Boston

Sponsor: Jessica D. St. Laurent, MD

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT07220239·Recruiting·Listed Oct 2025

Apply to this trial

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

for Infant, Extremely Premature

Sites in Boston +42 more locations

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 0 - 1

Code: NCT05685745·Recruiting·Listed Jan 2023

Apply to this trial

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for Colorectal Carcinoma

Sites in Boston +18 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 12 Months - 30

Code: NCT04851119·Phase 1, Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

for Anatomic Stage III Breast Cancer AJCC v8

Drug: Pidnarulex

Sites in Boston +1 more location

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07137416·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

for Metastatic Breast Cancer

1 location in Boston

Sponsor: Kristina A. Fanucci

Sex: All·Age: 18+

Code: NCT07198724·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

for Breast Cancer Female

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT06439693·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

for Breast Cancer

Sites in Boston +2 more locations

Sponsor: Nancy Lin, MD

Sex: All·Age: 18+

Code: NCT06176261·Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

for Breast Atypical Ductal Hyperplasia

Sites in Boston +9 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18 - 55

Code: NCT06184750·Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

for Depression

1 location in Boston

Sponsor: Boston University Charles River Campus

Sex: Female·Age: 15+·Accepts healthy volunteers

Code: NCT05624931·Recruiting·Listed Nov 2022

Apply to this trial

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

for Impaired Cognition

Sites in Boston & Salem

Sponsor: Massachusetts General Hospital

Sex: Female·Age: 60+·Accepts healthy volunteers

Code: NCT02290834·Recruiting·Listed Nov 2014

Apply to this trial

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

for Endometrial Cancer

3 locations in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: Female·Age: 18+

Code: NCT03675893·Phase 2·Recruiting·Listed Sep 2018

Apply to this trial

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

for Hypertension

1 location in Boston

Sponsor: Massachusetts General Hospital

Sex: Female·Age: 18+

Code: NCT06557005·Recruiting·Listed Aug 2024

Apply to this trial

Screening For BCRL In Targeted Therapy For Breast Cancer

for Lymphedema

1 location in Boston

Sponsor: Massachusetts General Hospital

Sex: Female·Age: 18 - 80

Code: NCT05142800·Recruiting·Listed Dec 2021

Apply to this trial

IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Specimens

for Infertility

1 location in Boston

Sponsor: Brigham and Women's Hospital

Sex: Male·Age: 18+

Code: NCT07074015·Recruiting·Listed Jul 2025

Apply to this trial

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

for Breast Cancer

Sites in Boston +3 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: Female·Age: 65+

Code: NCT05535192·Recruiting·Listed Sep 2022

Apply to this trial

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for Ovarian Cancer

Sites in Boston +8 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT05287451·Recruiting·Listed Mar 2022

Apply to this trial

BOLSTER: Learning New Skills to Thrive

for Gastrointestinal Cancer

Sites in Boston +1 more location

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT06936878·Recruiting·Listed Apr 2025

Apply to this trial

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

for Ovarian Cancer

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: Female·Age: 18+

Code: NCT06543537·Recruiting·Listed Aug 2024

Apply to this trial

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

for Platinum-resistant Ovarian Cancer

2 locations in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 85

Code: NCT06321484·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

Conditions in Women's health (Boston, MA)

Breast cancer· 79 Ovarian cancer· 38 Endometrial cancer· 31 Pregnancy· 12 Cervical cancer· 9 Fallopian tube cancer· 9 Premature / preterm birth· 3 Gynecologic cancer· 3 Preeclampsia· 2 Infertility· 2 Menopause· 2 Contraception· 2 Gestational diabetes· 1